CXCR7 antagonist-1
CXCR7 antagonist-1 is a selective small molecule inhibitor that blocks SDF-1 and I-TAC binding to the CXCR7 receptor. It has been utilized in research to investigate tumorigenesis and inflammatory diseases, demonstrating efficacy in suppressing tumor cell proliferation in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1613021-99-0
Product Name Alternative
CXCR7 antagonist1, CXCR-7 antagonist-1, CXCR7 antagonist-1, CXCR7, CXCR7 antagonist 1
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery, Stem Cell & Developmental Biology; Pharmacology & Drug Discovery
Purity
99.51% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.45 mM) ; DMSO:90 mg/mL (230.53 mM)
Smiles
Fc1ccc (cc1) -n1ccc (n1) C (=O) N[C@H]1CCN (C1) c1nccn2cccc12
Molecular Formula
C21H19FN6O
Molecular Weight
390.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), 0.2mg/mL
MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) (rMUC18/1130), CF488A conjugate, 0.1mg/mL
